長期投資家のためのIR情報
バリュートレンド

【9987】スズケン
医薬品卸。

売上高
営業利益
経常利益
当期利益
業績予想修正
対前回修正率
当初予想比較
決算期 日付 予・実 売上高
(百万円)
対前回 修正率 修正率 営業利益
(百万円)
対前回 修正率 修正率 経常利益
(百万円)
対前回 修正率 修正率 当期利益
(百万円)
対前回 修正率 修正率
2025.03 2025/02/12 Q3予 2,391,000 33,600 34,300 33,300
2025.03 2024/11/12 Q2予 2,391,000 33,600 34,300 33,300
2025.03 2024/08/09 Q1予 2,373,000 28,500 31,000 30,000
2025.03 2024/05/14 当初予 2,373,000 - 28,500 - 31,000 - 30,000 -
2024.03 2024/05/14 2,386,493 34,875 38,351 29,016
2024.03 2024/04/30 修正予 2,386,400 34,800 38,300 29,000
2024.03 2024/02/09 Q3予 2,326,700 24,900 27,900 24,200
2024.03 2023/11/10 修正予 2,326,700 24,900 27,900 24,200
2024.03 2023/08/09 Q1予 2,231,900 17,000 19,900 13,000
2024.03 2023/05/15 当初予 2,231,900 - 17,000 - 19,900 - 13,000 -
2023.03 2023/05/15 2,314,828 32,605 36,376 20,345
2023.03 2023/04/28 修正予 2,314,800 32,600 36,300 20,300
2023.03 2023/02/10 Q3予 2,271,000 24,900 28,000 18,000
2023.03 2022/11/11 Q2予 2,271,000 24,900 28,000 18,000
2023.03 2022/08/10 Q1予 2,223,000 18,800 21,700 14,000
2023.03 2022/05/11 当初予 2,223,000 - 18,800 - 21,700 - 14,000 -
2022.03 2022/05/11 2,232,774 13,777 23,418 14,393
2022.03 2022/04/26 修正予 2,232,000 13,700 23,400 14,300
2022.03 2022/02/09 Q3予 2,151,300 6,900 16,000 12,000
2022.03 2021/11/11 Q2予 2,151,300 6,900 16,000 12,000
2022.03 2021/08/06 修正予 - - - - - - 9,300
2022.03 2021/05/11 当初予 2,060,600 - 3,500 - 11,700 - 6,500 -
2021.03 2021/05/11 2,128,218 9,156 18,272 7,895
2021.03 2021/04/28 修正予 2,128,000 9,100 18,200 7,800
2021.03 2021/02/03 Q3予 2,122,000 4,000 12,300 4,000
2021.03 2020/11/05 当初予 2,122,000 - 4,000 - 12,300 - 7,500 -
2020.03 2020/05/11 2,213,478 32,571 41,467 28,213
2020.03 2020/04/28 修正予 2,213,000 32,500 41,400 28,200
2020.03 2020/02/05 Q3予 2,133,000 24,600 32,900 21,600
2020.03 2019/11/06 Q2予 2,133,000 24,600 32,900 21,600
2020.03 2019/08/05 Q1予 2,133,000 24,600 32,900 21,600
2020.03 2019/05/13 当初予 2,133,000 - 24,600 - 32,900 - 21,600 -
2019.03 2019/05/13 2,132,362 27,228 36,154 30,204
2019.03 2019/04/26 修正予 2,132,300 27,220 36,150 30,200
2019.03 2019/02/05 Q3予 2,081,700 21,550 30,450 26,600
2019.03 2018/11/27 修正予 2,081,700 21,550 30,450 26,600
2019.03 2018/11/06 Q2予 2,081,700 21,550 30,450 20,100
2019.03 2018/10/26 修正予 2,081,700 21,550 30,450 20,100
2019.03 2018/08/06 Q1予 2,070,000 18,100 - 26,600 17,000
2019.03 2018/05/09 当初予 2,070,000 - - - 26,600 - 17,000 -
2018.03 2018/05/09 - - - - - - - -
2018.03 2018/04/27 修正予 2,123,900 - - 29,000 18,800
2018.03 2018/02/05 Q3予 2,111,500 13,600 22,950 15,850
2018.03 2017/11/24 修正予 2,114,000 11,400 20,400 14,200
2018.03 2017/11/06 Q2予 2,100,000 10,300 19,000 12,100
2018.03 2017/08/04 Q1予 2,100,000 10,300 19,000 12,100
2018.03 2017/05/11 当初予 2,100,000 - 10,300 - 19,000 - 12,100 -
2017.03 2017/05/11 2,126,993 18,712 27,764 21,308
2017.03 2017/02/03 Q3予 2,105,000 19,900 29,000 22,300
2017.03 2016/11/08 修正予 2,105,000 19,900 29,000 22,300
2017.03 2016/08/05 Q1予 2,105,000 19,900 29,000 18,500
2017.03 2016/05/10 当初予 2,105,000 - 19,900 - 29,000 - 18,500 -
2016.03 2016/05/10 2,228,331 28,244 45,727 28,960
2016.03 2016/04/28 修正予 2,228,300 28,200 45,700 28,900
2016.03 2016/02/05 Q3予 2,157,300 18,000 34,800 22,000
2016.03 2015/11/04 Q2予 2,157,300 18,000 34,800 22,000
2016.03 2015/10/27 修正予 2,157,300 18,000 34,800 22,000
2016.03 2015/08/03 Q1予 2,043,000 12,400 - 28,700 17,700
2016.03 2015/05/11 当初予 2,043,000 - - - 28,700 - 17,700 -
2015.03 2015/05/11 - - - - - - - -
2015.03 2015/02/04 Q3予 2,007,000 13,470 30,070 17,600
2015.03 2014/11/05 Q2予 2,007,000 13,470 30,070 17,600
2015.03 2014/08/04 Q1予 2,007,000 13,470 30,070 17,600
2015.03 2014/05/09 当初予 2,007,000 - 13,470 - 30,070 - 17,600 -
2014.03 2014/05/09 1,988,216 17,840 35,320 21,447
2014.03 2014/04/28 当初予 1,988,200 - 17,800 - 35,300 - 21,400 -
シェア ツイート
ページトップへ戻る